top of page
Search

Why Your ADHD Medication May Feel Different Throughout the Month

  • Writer: Sameera Devulapally
    Sameera Devulapally
  • Jul 6
  • 5 min read

Have you ever felt like your ADHD medication seems to work perfectly one week, only to stop working the next?

Many women with ADHD describe experiencing that pattern exactly. They often find themselves suddenly struggling to focus, feeling more forgetful, emotionally overwhelmed, or mentally exhausted despite taking the same medication at the same dose. For years, these challenges were often dismissed as stress, lack of sleep, or simply part of the menstrual cycle. Researchers are now beginning to uncover a more complex explanation: hormonal fluctuations may influence both ADHD symptoms and how well ADHD medications work.

As more women are diagnosed with ADHD later in life, scientists are recognizing that much of the existing knowledge about ADHD was originally based on studies of boys and men. New research suggests that women may experience ADHD differently, and that hormones may play a larger role in treatment than previously understood.


ADHD, Dopamine, and the Female Brain

ADHD is a neurodevelopmental condition that affects attention, impulse control, motivation, and executive functioning. Many of these functions rely on neurotransmitters such as dopamine and norepinephrine. Stimulant medications, including Adderall, Vyvanse, and Ritalin, help improve symptoms by increasing the availability of these neurotransmitters in the brain [1].

However, dopamine does not operate alone. Researchers have found that estrogen also influences dopamine signaling. Higher estrogen levels appear to enhance dopamine activity, while lower estrogen levels may reduce it [2]. This connection has led researchers to ask an important question: if hormones influence dopamine, could hormonal fluctuations also influence ADHD symptoms and medication effectiveness?


Why Symptoms May Change Throughout the Month

The menstrual cycle involves predictable changes in hormone levels, particularly estrogen and progesterone. During the first half of the cycle known as the follicular phase, estrogen gradually rises and peaks around ovulation. During the second half, or the luteal phase, estrogen levels begin to decline while progesterone becomes more dominant.

Many women with ADHD report that this is when symptoms become more noticeable. Difficulty concentrating, forgetfulness, brain fog, emotional sensitivity, irritability, and fatigue often worsen in the days leading up to menstruation. Some women also report feeling as though their ADHD medication is no longer working as effectively as it usually does [3].

Although researchers are still investigating the exact mechanisms involved, declining estrogen levels may contribute to changes in dopamine signaling that make ADHD symptoms more difficult to manage during this phase of the cycle. Higher progesterone levels during the luteal phase may also play a role, as progesterone has been shown to reduce some subjective effects of stimulant drugs such as d-amphetamine [4].


When Medication Feels Less Effective

One of the most intriguing findings in recent ADHD research involves the relationship between stimulant medications and the menstrual cycle. Stimulants are the most commonly prescribed medications for ADHD and work by increasing the availability of neurotransmitters such as dopamine and norepinephrine, helping improve attention, focus, and impulse control. 

In a small study of women with ADHD, researchers observed that participants consistently experienced worsening ADHD symptoms during the premenstrual phase despite taking stable medication doses. When stimulant doses were temporarily adjusted under medical supervision, participants reported improvements in focus, mood, energy, and emotional regulation [3]. While larger studies are still needed, these findings suggest that hormonal fluctuations may influence how some women respond to ADHD medications throughout the month.

This does not mean women should change their medication on their own. Rather, it highlights the importance of discussing symptom patterns with a healthcare provider and recognizing that treatment response may not always be constant.


ADHD Across a Woman's Life

Art by Shea Davis
Art by Shea Davis

Hormonal influences on ADHD are not limited to the menstrual cycle. According to clinician and researcher Patricia Quinn, hormonal transitions throughout a woman's life may affect both symptom severity and treatment needs [5]. Puberty, pregnancy, postpartum recovery, perimenopause, and menopause are all periods marked by significant hormonal changes that may influence attention, mood, and executive functioning.

Some women first begin to struggle academically during adolescence as hormonal changes become more pronounced. Others report worsening symptoms during perimenopause, when estrogen levels begin to decline and memory, concentration, and organization become more challenging.

Viewing ADHD through a lifespan perspective helps explain why symptoms may change over time and why treatment approaches that work during one stage of life may need adjustment during another.


Why So Many Women Are Diagnosed Later

Historically, ADHD has been associated with hyperactive young boys who struggle to sit still in the classroom. Girls often present differently.

Instead of obvious hyperactivity, many women experience inattentiveness, chronic disorganization, emotional dysregulation, forgetfulness, and feelings of overwhelm. Because these symptoms are less disruptive, they are often overlooked or attributed to anxiety, stress, or personality traits rather than ADHD [1].

As a result, many women are not diagnosed until adulthood, sometimes after years of struggling to understand why tasks that seem simple for others feel disproportionately difficult.


Looking Forward

Researchers still have much to learn about the relationship between hormones and ADHD. More studies are needed to understand how hormonal fluctuations influence symptoms, medication response, and long-term treatment outcomes.

However, one message is becoming increasingly clear: ADHD treatment may not be one-size-fits-all.

For many women, hormones may be an important piece of the puzzle. Understanding how estrogen, dopamine, and ADHD interact could lead to more personalized treatment strategies and help explain experiences that many women have reported for years.

If you personally have noticed changes in your symptoms throughout the month, it may be worth mentioning to your healthcare provider. In recent years, some women have begun to adjust their dosage to match their hormonal cycles with great success. As research continues to evolve, women with ADHD may finally gain a clearer answer to a question that has long gone unexplained:

Why does my ADHD feel different depending on the time of the month?


References

  1. Amiri D, Briziarelli L, Tempesta E. Gender disparities in ADHD medication efficacy: investigating treatment outcomes for females compared to males. Middle East Current Psychiatry. 2025 Mar 7;32. doi:10.1186/s43045-025-00508-y

  2. Rapoport IL, Groenman AP. A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions. J Atten Disord. 2025 Jun;29(8):602–16. doi:10.1177/10870547251315601 PubMed PMID: 39878255; PubMed Central PMCID: PMC12064863.

  3. de Jong M, Wynchank DSMR, van Andel E, Beekman ATF, Kooij JJS. Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage. Front Psychiatry. 2023 Dec 13;14. doi:10.3389/fpsyt.2023.1306194

  4. Justice AJ, de Wit H. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl). 1999 Jul;145(1):67–75. doi:10.1007/s002130051033 PubMed PMID: 10445374.

  5. Quinn PO. ADHD and the female life cycle: A guide for clinicians. [New York]: Brunner-Routledge; 2005.



Comments


CONTACT US

Have suggestions, comments, or concerns? Contact us using any of the methods below!

  • Instagram
  • Facebook
  • Linkedin

BE THE FIRST TO KNOW

Sign up to our newsletter to stay informed

© 2025 OvaCare Equity Project.

bottom of page